LRRK2-IN-17
LRRK2-IN-17 is an orally active LRRK2 inhibitor with IC50 values of 3.5 nM for WT and 3.3 nM for G2019S, and it also inhibits RET kinase with an IC50 of 59 nM. LRRK2-IN-17 is utilized in research related to cancer and Parkinson's disease (PD) .
Product Specifications
CAS Number
2101821-86-5
Field of Research
Cell Biology, Signal Transduction
Smiles
N (C1=C2C (=NC (NC=3N=NN (C) C3) =N1) NC=C2) [C@@H]4C=5C (CC4) =CC=CC5
Molecular Formula
C18H18N8
Molecular Weight
346.39
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
VAng-Lsx7629-1mgEcoli 1 mg (E. coli)
Recombinant Clostridium Acetobutylicum hisA Protein (aa 1-239)
Sign In for Pricing
View Details 
orb2903626-01 20 µg
Recombinant Bifunctional lycopene cyclase/phytoene synthase (carRA)
Sign In for Pricing
View Details orb2903626-02 100 µg
Recombinant Bifunctional lycopene cyclase/phytoene synthase (carRA)
Sign In for Pricing
View Details 